Qube Research & Technologies LTD My Md Pharmaceuticals, Inc. Transaction History

Qube Research & Technologies LTD

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	BUY	$0.47 - $1.87 $31 - $123	66 New	66 $0
Q2 2022 Aug 15, 2022	SELL	$2.0 - $4.78 $41,792 - $99,882	-20,896 Closed	0 $0
Q1 2022 May 09, 2022	SELL	$3.34 - $6.05 $2,598 - $4,706	-778 Reduced 3.59%	20,896 $97,000
Q4 2021 Feb 01, 2022	BUY	$5.46 - $9.69 $118,340 - $210,021	21,674 New	21,674 $131,000

30.2K

Ticker MYMD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 39,470,000
Market Cap $67.5M
Description
MyMD Pharmaceuticals, Inc., a clinical development stage pharmaceutical company, focuses on developing various therapeutic platforms to treat the causes of disease. The company is developing MYMD-1, a drug platform based on a clinical stage small molecule that regulates the immune system to control TNF-a, which drives chronic inflammation, and o...

Get notified when there are updates to the investment portfolio of Qube Research & Technologies LTD, based on Form 13F filings with the SEC.

Stay updated on Qube Research & Technologies LTD with notifications on news.